Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Epidemiology (Cambridge, Mass.)|March 7, 2002
Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based studyLars Frost, Søren Paaske Johnsen, Lars Pedersen, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 26, 2017
Setting priorities in the health care sector - the case of oral anticoagulants in nonvalvular atrial fibrillation in DenmarkPeter Bo Poulsen, Søren Paaske Johnsen, Morten Lock Hansen, et al.
Archives of Internal Medicine|February 14, 2007
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and VHarvey D White, Michael Gruber, Jan Feyzi, et al.
Clinical Cardiology|May 15, 2013
Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish surveyAxel Brandes, Mikkel Overgaard, Liane Plauborg, et al.
Journal of the American College of Cardiology|November 6, 2007
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trialChristopher P Cannon, Steen Husted, Robert A Harrington, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Recent advances in the diagnosis and treatment of deep vein thrombosis: a regional consensusMohamad Qari, Hikmat Abdel-Razeq, Abdulaziz Alzeer, et al.
European Heart Journal|December 25, 2004
Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study populationMichael D Jacobsen, Galen S Wagner, Lene Holmvang, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 24, 2012
Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney diseaseJohn W Eikelboom, Stuart J Connolly, Peggy Gao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 5, 2019
Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversionWillemijn J Comuth, Moniek P M de Maat, Daan van de Kerkhof, et al.
Pageof 10